{"id":"W2137755123","doi":"10.1371/journal.pone.0063359","title":"In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Argonne National Laboratory; National Center for Advancing Translational Sciences; National Center for Research Resources; National Institutes of Health; National Cancer Institute; Office of Science; University of Alberta; U.S. Department of Energy","keywords":"Neuroblastoma; In silico; Antibody; Monoclonal antibody; Chemistry; Melanoma; Docking (animal); Cancer research; Antigen; Molecular biology; Biochemistry; Biology; Cell culture; Medicine; Immunology; Genetics; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025316,0.0007153248,0.0007663483,0.0002139006,0.0002567387,0.0004963493,0.0006766901,0.0006006987,0.003047051],"category_scores_gemma":[0.0006108296,0.0003385639,0.0006247188,0.0001852514,0.0002147874,0.0002628088,0.0003105451,0.0007672515,0.0006015879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005149227,"about_ca_system_score_gemma":0.001107368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002248594,"about_ca_topic_score_gemma":0.003006653,"domain_scores_codex":[0.9998851,0.00002518748,0.000004092809,0.00002026264,0.00003281795,0.00003256426],"domain_scores_gemma":[0.9998595,0.00005827657,0.00001736953,0.00001187407,0.00003266046,0.00002027217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0009157605,0.0004662906,0.00352301,0.0003635442,0.0001513563,0.0009088385,0.0000864609,0.8325624,0.1270951,0.003643875,0.002354229,0.02792907],"study_design_scores_gemma":[0.0001648324,0.0005016918,0.0006464727,0.00001586442,0.0000860559,0.0001479678,0.00006285089,0.964174,0.02833844,0.0007713086,0.005072149,0.00001842351],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.920095,0.001051325,0.0651513,0.0005130355,0.0002022488,0.0002368794,0.0009420943,0.001607202,0.01020091],"genre_scores_gemma":[0.9430429,0.0004292022,0.05297962,0.0001327465,0.00001320145,0.0001910027,0.001122955,0.0002100709,0.001878411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003047051,"threshold_uncertainty_score":0.01019341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06253626835361738,"score_gpt":0.3419945704935322,"score_spread":0.2794583021399148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}